Pregnancy-induced decrease in the relaxant effect of terbutaline in the late-pregnant rat myometrium: role of G-protein activation and progesterone
Authors:
- 1 July 2005
- journal article
- Published by Oxford University Press (OUP) in Reproduction
- Vol. 130 (1) , 113-122
Abstract
The effectiveness of β2-agonists in preterm delivery is reduced by several factors. The aim of this study was to determine the influence of late pregnancy in the uterus-relaxing effect of terbutaline in the rat in vitro. Rat uterine tissues from late pregnancy (days 15, 18, 20 and 22) were used. In vitro electrical field-stimulation (EFS) was used to evoke contractions. The radioligand-binding technique, reverse transcription-polymerase chain reaction and radioimmunoassay technique were used to determine the β-adrenergic receptor density and mRNA level and the plasma sex hormone level, respectively. The activated G-protein level of the β-adrenergic receptors was investigated by a radiolabelled GTP binding assay. EFS-induced contractions were inhibited by terbutaline. This effect decreased towards term with respect to both the EC50 and maximal inhibition values. A drop in plasma progesterone level was also detected. Binding studies revealed an increase in β-adrenergic receptor number on the last day of pregnancy, which correlated with the change in receptor mRNA level. The G-protein-activating effect of terbutaline decreased continuously between days 15 and 20. Surprisingly, terbutaline decreased the G-protein activation to below the basal level on day 22. However, progesterone pretreatment set back the uterine action of terbutaline, increased the density of the β2-adrenergic receptors and their mRNA level and increased the G-protein-activating property of terbutaline. These data provide evidence of a pregnancy-induced decrease in activated G-protein level after β2-agonist stimulation. The decrease in plasma progesterone level has a crucial role in this process. The effects of β2-adrenergic receptor agonists in tocolytic therapy may possibly be potentiated with progesterone. Abstract The effectiveness of β2-agonists in preterm delivery is reduced by several factors. The aim of this study was to determine the influence of late pregnancy in the uterus-relaxing effect of terbutaline in the rat in vitro. Rat uterine tissues from late pregnancy (days 15, 18, 20 and 22) were used. In vitro electrical field-stimulation (EFS) was used to evoke contractions. The radioligand-binding technique, reverse transcription-polymerase chain reaction and radioimmunoassay technique were used to determine the β-adrenergic receptor density and mRNA level and the plasma sex hormone level, respectively. The activated G-protein level of the β-adrenergic receptors was investigated by a radiolabelled GTP binding assay. EFS-induced contractions were inhibited by terbutaline. This effect decreased towards term with respect to both the EC50 and maximal inhibition values. A drop in plasma progesterone level was also detected. Binding studies revealed an increase in β-adrenergic receptor number on the last day of pregnancy, which correlated with the change in receptor mRNA level. The G-protein-activating effect of terbutaline decreased continuously between days 15 and 20. Surprisingly, terbutaline decreased the G-protein activation to below the basal level on day 22. However, progesterone pretreatment set back the uterine action of terbutaline, increased the density of the β2-adrenergic receptors and their mRNA level and increased the G-protein-activating property of terbutaline. These data provide evidence of a pregnancy-induced decrease in activated G-protein level after β2-agonist stimulation. The decrease in plasma progesterone level has a crucial role in this process. The effects of β2-adrenergic receptor agonists in tocolytic therapy may possibly be potentiated with progesterone.Keywords
This publication has 38 references indexed in Scilit:
- The [35S]GTPγS binding assay: approaches and applications in pharmacologyLife Sciences, 2003
- Concomitant Increase of G Protein-Coupled Receptor Kinase Activity and Uncoupling of -Adrenergic Receptors in Rat Myometrium at ParturitionEndocrinology, 2001
- Characterization of late-pregnant rat uterine contraction via the contractility ratio in vitro Significance of α1-adrenoceptorsLife Sciences, 2001
- Neonatal effects of nifedipine and ritodrine for preterm laborObstetrics & Gynecology, 2000
- Expression of β-adrenergic receptor kinase subtypes in the pregnant rat myometriumAmerican Journal of Obstetrics and Gynecology, 1997
- Multiple mechanisms of heterologous β-adrenoceptor regulation in rat uterusJournal of Endocrinology, 1995
- Pregnancy-related modifications of rat myometrial Gs proteins: ADP ribosylation, immunoreactivity and gene expression studiesJournal of Molecular Endocrinology, 1994
- Regulation by progesterone of the high-affinity state of myometrial β-adrenergic receptor and of adenylate cyclase activity in the pregnant ratJournal of Molecular Endocrinology, 1991
- Changes in the response to adrenergic drugs on mouse uterine contractions during pregnancyLife Sciences, 1990
- CHARACTERIZATION OF β‐ADRENOCEPTORS IN MYOMETRIUM OF PREPARTURIENT RATSFundamental & Clinical Pharmacology, 1988